Jeremy Comeaux, MD
Physical Medicine & Rehabilitation · Baton Rouge, LANPI 1588834410
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 32 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 8 manufacturers reported payments, led by IBSA Pharma Inc. at 38.9% of the total. Reporting peaked in 2021 at $215 and has fallen 79.7% since, to $44 in 2025.
Across 32 payments — averaging $18.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- IBSA Pharma Inc.$226
- Pfizer$182
- Johnson & Johnson$73
- Boston Scientific$31
- Amgen$23
- Zyla Life Sciences, Inc.$20
- plus $27 from 2 others
What the payments were for
- Food & beverage$581100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| IBSA Pharma Inc. | 13 | $226 |
| Pfizer | 9 | $182 |
| Johnson & Johnson | 4 | $73 |
| Boston Scientific | 2 | $31 |
| Amgen | 1 | $23 |
| Zyla Life Sciences, Inc. | 1 | $20 |
| Si-bone, Inc. | 1 | $16 |
| Scilex Pharmaceuticals Inc. | 1 | $11 |
How this compares
$581 in reported general payments places this provider in the 60th percentile of 117 physical medicine & rehabilitation providers in Louisiana.
See all physical medicine & rehabilitation providers in Louisiana →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 380 | $2,678 |
| Lidocaine | 13 | $2,171 |
| Metaxalone | 23 | $1,209 |
| Tramadol Hcl ErTramadol Hcl | 28 | $1,197 |
| Gabapentin | 150 | $1,072 |
| Pregabalin | 14 | $693 |
| Tizanidine Hcl | 172 | $624 |
| Diclofenac Sodium | 34 | $603 |
| Tramadol Hcl | 165 | $434 |
| Duloxetine Hcl | 12 | $217 |
| Meloxicam | 34 | $182 |
| Methocarbamol | 18 | $132 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 13 | $108 |
| Diazepam | 34 | $19 |
Paid to pharmacies, not to this prescriber.
Other physical medicine & rehabilitation in Baton Rouge
- Ayman HamedBaton Rouge$7K
- John E NyboerBaton Rouge$7K
- Scott NyboerBaton Rouge$7K
- Matthew CutrerBaton Rouge$6K
- Christopher BelleauBaton Rouge$3K
- Gray BarrowBaton Rouge$1K
- Mary AndersonBaton Rouge$917
- Kevin HaynesBaton Rouge$449
- Zachary DawesBaton Rouge$212
- William RogenmoserAlexandria$350K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.